As the world hopes for an HIV vaccine following recent positive developments, a new study in South Africa shows that a vaginal gel made using Gilead Sciences' AIDS drug Viread cut HIV infections in women by as much as 50%.
The NIH says the two naturally occurring, powerful antibodies came an HIV-infected individual. Scientists found these antibodies not only neutralize more HIV strains, but do so with greater strength than previously known antibodies.
He's young, charismatic, innovative and has got heart. At least that's the impression GlaxoSmithKline CEO Andrew Witty gives to the outside world. GSK is allowing free access to its library of 13,500 potential malaria treatments. Is he genuinely a do-gooder or just good at PR?